With extensive experience in aptamer development, our scientists are confident in providing a full range of aptamer screening services to advance science and technology development. Creative Biolabs is able to provide aptamer screening services in an efficient and high-quality manner.
SELEX technology can be used to obtain aptamers with specific binding ability to the target. Aptamers have been shown to partially replace antibodies in research and clinical applications, and are a promising technology area.
Fig 1. Schematic diagram of the SELEX process [1].
The key to the development of aptamer technology is the screening of aptamers with high affinity and specificity for the target. Over the past decade, the aptamer screening technology has been improved to improve the efficiency and effectiveness of screening, and new methods such as ablation screening, compound target screening, genomic screening, capillary screening, etc. have been generated to promote the development of this technology.
Fig 2. Important advantages of aptamer over antibody [1].
Similar to monoclonal antibodies, aptamers can specifically recognize and bind to their targets. Due to their simple preparation, ease of modification and stability, aptamers have been used in various fields of molecular biology, biotechnology and biomedicine.
Aptamers as Diagnostics |
|
Biosensors |
|
Aptamer Therapeutics |
|
With our technology platform, Creative Biolabs provides high-quality aptamer screening services.
We committed to help our customers obtain high-quality aptamers more efficiently. If you are interested in this service, please contact us for more details.
Creative Biolabs provides the most comprehensive services for aptamer development projects. Our cutting-edge technology allows our researchers to fulfill your requirement from various aspects and to offer the most suitable solution for your project.
Reference